The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Prognostic value of PSA progression in metastatic castration-resistant prostate cancer (mCRPC) patients (pts) treated in the COU-AA-302 trial.
 
David Lorente
Consulting or Advisory Role - Bayer; Janssen
Speakers' Bureau - Astellas Medivation; Bayer; Janssen; Merck; Sanofi
Travel, Accommodations, Expenses - Astellas Medivation; Janssen; Sanofi
 
Rebeca Lozano
Speakers' Bureau - Janssen-Cilag; Roche
Travel, Accommodations, Expenses - Janssen-Cilag; Roche
 
Guillermo de Velasco
Consulting or Advisory Role - Astellas Medivation; Bayer; Bristol-Myers Squibb; Janssen; Novartis; Pfizer; Pierre Fabre
Research Funding - Ipsen
Other Relationship - Janssen
 
Maria De Julian
No Relationships to Disclose
 
Miguel Rodrigo
No Relationships to Disclose
 
Angel L Sanchez
No Relationships to Disclose
 
Carlos Di Capua
No Relationships to Disclose
 
Elena Castro
Honoraria - Astellas Pharma; AstraZeneca; Bayer; Janssen-Cilag
Consulting or Advisory Role - Bayer; Bayer (I); Janssen; Janssen (I)
Research Funding - AstraZeneca (Inst); Bayer (Inst); Janssen (Inst)
Travel, Accommodations, Expenses - Astellas Pharma; Bayer; Janssen; Roche
 
Alfredo Sanchez Hernandez
Honoraria - Astellas Pharma; AstraZeneca; Bayer; Boehringer Ingelheim; Bristol-Myers Squibb; Janssen; Kyowa Hakko Kirin; Lilly; Merck Sharp & Dome; Pfizer; Pierre Fabre; Roche/Genentech; Sanofi
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Bayer; Boehringer Ingelheim; Bristol-Myers Squibb; Janssen; Kyowa Hakko Kirin; Lilly; Merck Sharp & Dome; Pfizer; Pierre Fabre; Roche/Genentech; Sanofi
 
David Olmos
Honoraria - Bayer; Janssen; Sanofi
Consulting or Advisory Role - AstraZeneca; Bayer; Clovis Oncology; Janssen
Research Funding - Astellas Medivation (Inst); AstraZeneca (Inst); Bayer (Inst); Genentech/Roche (Inst); Janssen (Inst); Pfizer (Inst); Tokai Pharmaceuticals (Inst)
Travel, Accommodations, Expenses - Bayer; Ipsen; Janssen